— Know what they know.
Not Investment Advice
Also trades as: EFTRW (NASDAQ) · $vol 0M

EFTR OTC

eFFECTOR Therapeutics, Inc.
1W: +0.0% 1M: -75.0% 3M: -66.7% YTD: +0.0% 1Y: +0.0% 3Y: -100.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 48 · $941 mcap · 5M float · 0.043% daily turnover · Short 48% of daily vol

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
Analyst Recommendations
Strong Buy: 0Buy: 6Hold: 0Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$—
Analysts0
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2024-04-04 Stifel Nicolaus — Initiated $10 — +237.8% $2.96
2023-01-09 JMP Securities — Initiated $1 — +127.3% $0.44

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A+
Profitability
—
Balance Sheet
24
Earnings Quality
32
Growth
32
Value
15
Momentum
37
Safety
0
Cash Flow
30

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-12.65
Distress Zone
Piotroski F-Score
4/9
✗ ✗ ✓ ✓ ✓ ✓ ✗ ✗ ✗
Beneish M-Score
—
—
Ohlson O-Score
2.93
Bankruptcy prob: 94.9%
High Risk
Credit Rating
CCC
Score: 16.7/100
Trend: Improving
Earnings Quality
—
OCF/NI: 0.84x
Accruals: -22.2%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. EFTR scores -12.65, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. EFTR scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. EFTR's implied 94.9% bankruptcy probability signals significant financial distress. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. EFTR receives an estimated rating of CCC (score: 16.7/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-0.00x
PEG
-0.00x
P/S
0.00x
P/B
-0.00x
P/FCF
-1.31x
P/OCF
—
EV/EBITDA
-1.05x
EV/Revenue
205.47x
EV/EBIT
-1.05x
EV/FCF
-1.14x
Earnings Yield
-90.13%
FCF Yield
-76.20%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. EFTR currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
1.094
EBT / EBIT
×
EBIT Margin
-195.383
EBIT / Rev
×
Asset Turnover
0.007
Rev / Assets
×
Equity Multiplier
-12.308
Assets / Equity
=
ROE
1737.6%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. EFTR's ROE of 1737.6% is driven by Asset Turnover (0.007), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1389 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$0.00
Median 1Y
$0.00
5th Pctile
$0.00
95th Pctile
$0.00
Ann. Volatility
461.0%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Stephen T. Worland,
Ph.D. President and Chief Executive Officer
$566,500 $— $3,843,052
Michael Byrnes Financial
ancial Officer
$435,735 $— $1,975,301
Alana McNulty Business
hief Business Officer
$255,921 $— $1,611,534
Premal Patel, M.D.,
Ph.D. Former Chief Medical Officer
$164,270 $— $935,815
Douglas Warner, M.D.
Chief Medical Officer
$179,135 $— $711,962

CEO Pay Ratio

5:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $3,843,052
Avg Employee Cost (SGA/emp): $780,357
Employees: 14

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
14
-6.7% YoY
Revenue / Employee
—
Profit / Employee
$-2,557,929
NI: $-35,811,000
SGA / Employee
$780,357
Avg labor cost proxy
R&D / Employee
$1,637,071
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Current
ROE 1.2% 8.4% 42.4% 91.4% 2.6% -38.7% 2.9% -2.1% -3.5% -3.4% -9.5% 37.7% 17.4% 17.38%
ROA -38.4% -84.9% -5.4% 29.2% 76.4% 83.4% 11.7% -54.5% -1.0% -1.1% -1.3% -1.4% -1.4% -1.41%
ROIC 1.2% 6.3% 36.1% -4.3% 69.1% 2.5% 3.1% 12.0% 8.0% 13.7% 21.4% 7.5% 6.1% 6.08%
ROCE 1.2% -1.3% -14.5% 35.1% 58.4% 1.3% 65.8% -5.1% 7.0% -11.0% 9.7% 6.3% -20.3% -20.26%
Gross Margin — -4.9% 98.6% 99.7% — 99.9% — — — — — 81.5% — —
Operating Margin — -7.3% -20.4% 14.0% — -3.9% — — — — — -53.1% — —
Net Margin — -8.0% 20.8% 13.3% — -3.4% — — — — — -56.4% — —
EBITDA Margin — -7.3% 22.0% -8.7% — -3.2% — — — — — -51.5% — —
FCF Margin — -15.6% -17.8% -9.8% -10.4% -6.5% -7.1% -13.0% -13.5% — — -183.0% -180.7% -180.71%
OCF Margin — -15.6% -17.8% -9.8% -10.4% -6.5% -7.0% -12.9% -13.4% — — -182.4% -180.2% -180.19%
ROA 3Y Avg snapshot only -79.75%
ROIC Economic snapshot only -1.24%
Cash ROA snapshot only -1.08%
NOPAT Margin snapshot only -161.66%
Pretax Margin snapshot only -213.77%
R&D / Revenue snapshot only 133.24%
SGA / Revenue snapshot only 68.44%
SBC / Revenue snapshot only 27.40%
Valuation
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Current
P/E Ratio -22.16 -18.39 -174.47 21.17 6.84 2.42 4.17 -0.78 -0.41 -1.07 -1.03 -0.87 -1.11 -0.000
P/S Ratio — 322.37 506.87 131.20 68.25 15.10 6.84 8.84 7.37 — — 192.67 237.16 0.000
P/B Ratio -26.94 -1.55 -73.96 19.35 6.89 2.98 2.04 4.56 -3.08 15.42 -9.34 -5.39 46.46 -0.000
P/FCF -29.19 -20.63 -28.52 -13.41 -6.57 -2.32 -0.97 -0.68 -0.55 -1.27 -1.20 -1.05 -1.31 -1.312
P/OCF — — — — — — — — — — — — — —
EV/EBITDA -23.55 -20.51 -275.19 -21.26 -32.85 -6.37 -0.45 -0.58 -0.49 -1.02 -1.19 -1.01 -1.05 -1.045
EV/Revenue — 335.15 475.61 119.56 58.19 9.70 3.14 5.84 8.03 — — 206.09 205.47 205.467
EV/EBIT -23.53 -20.44 -269.20 17.35 5.42 1.44 1.41 -0.58 -0.49 -1.02 -1.20 -1.02 -1.05 -1.052
EV/FCF -29.55 -21.45 -26.76 -12.22 -5.60 -1.49 -0.44 -0.45 -0.59 -1.12 -1.29 -1.13 -1.14 -1.137
Earnings Yield -4.5% -5.4% -0.6% 4.7% 14.6% 41.2% 24.0% -1.3% -2.4% -93.7% -97.0% -1.1% -90.1% -90.13%
FCF Yield -3.4% -4.8% -3.5% -7.5% -15.2% -43.1% -1.0% -1.5% -1.8% -78.8% -83.2% -95.0% -76.2% -76.20%
Price/Tangible Book snapshot only 46.458
EV/Gross Profit snapshot only 652.661
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Current
Current Ratio 0.75 2.23 1.27 13.30 18.38 1.79 1.42 1.12 0.78 1.09 0.82 0.77 1.03 1.027
Quick Ratio 0.75 2.23 1.28 13.32 18.38 1.81 1.42 1.12 0.78 1.10 0.82 0.77 1.03 1.027
Debt/Equity -3.43 -0.14 -2.58 1.16 0.80 1.03 1.75 5.21 -4.23 7.93 -5.16 -3.55 24.48 24.484
Net Debt/Equity — — — -1.72 -1.02 -1.06 -1.10 -1.55 — -1.79 — — -6.21 -6.209
Debt/Assets 1.08 1.38 0.33 0.37 0.41 0.46 0.55 0.70 0.93 0.76 1.02 1.00 0.75 0.746
Debt/EBITDA -2.96 -1.74 -10.23 -1.40 -4.44 -3.42 -0.83 -1.00 -0.61 -0.59 -0.62 -0.62 -0.64 -0.636
Net Debt/EBITDA -0.28 -0.78 18.09 2.07 5.68 3.55 0.53 0.30 -0.04 0.13 -0.08 -0.07 0.16 0.161
Interest Coverage -20.51 -14.43 -1.55 9.96 14.15 13.28 3.76 -9.07 -13.53 -12.89 -11.58 -11.27 -10.63 -10.625
Equity Multiplier -3.17 -0.10 -7.82 3.13 1.96 2.22 3.17 7.46 -4.56 10.44 -5.08 -3.55 32.81 32.807
Cash Ratio snapshot only 0.993
Debt Service Coverage snapshot only -10.689
Cash to Debt snapshot only 1.254
FCF to Debt snapshot only -1.446
Defensive Interval snapshot only 283.8 days
Efficiency & Turnover
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Current
Asset Turnover 0.00 0.05 0.02 0.05 0.08 0.13 0.07 0.05 0.06 0.00 0.00 0.01 0.01 0.007
Inventory Turnover — — — — — — — — — — — — — —
Receivables Turnover 0.00 1.38 — 25.49 3.64 15.47 — 31.67 — — — 4.10 19.06 19.059
Payables Turnover 0.02 2.14 12.73 7.92 10.87 0.01 0.02 0.01 0.00 0.02 0.05 0.04 0.04 0.040
DSO — 264 0 14 100 24 0 12 0 — — 89 19 19.2 days
DIO 0 0 -18 -9 0 -4056 -3042 -2897 0 -3190 -79 -59 0 0.0 days
DPO 23881 171 29 46 34 31542 23345 45671 248687 17946 8092 8391 9054 9054.3 days
Cash Conversion Cycle — 93 -47 -41 67 -35574 -26386 -48556 -248687 — — -8361 -9035 -9035.2 days
Fixed Asset Turnover snapshot only 0.390
Cash Velocity snapshot only 0.006
Capital Intensity snapshot only 167.475
Growth (YoY)
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Current
Revenue — — — — — 4.6% 2.1% -21.1% -21.1% -1.0% -1.0% -91.9% -91.9% -91.94%
Net Income — — — — 4.9% 3.0% 2.7% -2.4% -2.4% -2.5% -7.4% -58.0% 3.1% 3.13%
EPS — — — — 2.3% 2.1% 2.7% -2.4% -2.5% -2.3% -5.2% 1.6% 39.0% 39.04%
FCF — — — — -4.3% -1.3% -22.4% -4.7% -2.6% -24.2% -26.6% -13.6% -7.7% -7.68%
EBITDA — — — — 28.0% 48.0% -11.5% -42.0% -6.4% -4.8% -37.3% -62.5% 4.1% 4.12%
Op. Income — — — — 95.2% 71.1% 81.3% -61.7% -126.8% -10.4% -8.4% -5.8% 6.3% 6.33%
OCF Growth snapshot only -7.96%
Asset Growth snapshot only 23.73%
Debt Growth snapshot only -0.48%
Shares Change snapshot only 58.92%
Growth (CAGR)
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Current
Revenue 3Y — — — — — — — — — — — — — —
Revenue 5Y — — — — — — — — — — — — — —
EPS 3Y — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — — — — — —
Gross Profit 5Y — — — — — — — — — — — — — —
Op. Income 3Y — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — —
Assets 3Y — — — — — — — — — — — — 16.5% 16.52%
Assets 5Y — — — — — — — — — — — — — —
Equity 3Y — — — — — — — — — — — — — —
Book Value 3Y — — — — — — — — — — — — — —
Dividend 3Y — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Current
Revenue Stability — — — — — — — — 0.56 0.03 0.10 0.91 0.00 0.000
Earnings Stability — — — — — — — — 0.23 0.17 0.56 0.93 0.42 0.422
Margin Stability — — — — — — — — — — — 0.00 0.00 0.000
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence — — — — — — — — 0.20 0.20 0.20 0.50 0.50 0.500
Earnings Smoothness — — — — — — — — — — — — — —
ROE Trend — — — — — — — — — — — — — —
Gross Margin Trend — — — — — — — — — — — 0.29 0.12 0.117
FCF Margin Trend — — — — — — — — — — — -171.63 -168.75 -168.755
Sustainable Growth Rate — — — 91.4% 2.6% — 2.9% — — — — — — —
Internal Growth Rate — — — 41.3% 3.2% 5.0% 13.2% — — — — — — —
Cash Flow Quality
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Current
OCF/Net Income 0.76 0.89 6.12 -1.58 -1.04 -1.04 -4.27 1.14 0.76 0.84 0.86 0.83 0.84 0.843
FCF/OCF 1.00 1.00 1.00 1.00 1.00 1.01 1.01 1.01 1.01 1.00 1.00 1.00 1.00 1.003
FCF/Net Income snapshot only 0.845
CapEx/Revenue — 0.0% 0.5% 1.6% 3.9% 4.6% 6.2% 9.5% 7.4% — — 59.9% 51.9% 51.85%
CapEx/Depreciation snapshot only 0.757
Accruals Ratio -0.09 -0.09 0.28 0.75 1.56 1.70 0.62 0.08 -0.24 -0.17 -0.18 -0.25 -0.22 -0.222
Sloan Accruals snapshot only 0.258
Cash Flow Adequacy snapshot only -347.512
Dividends & Buybacks
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — 0.0% 0.0% 0.0% 0.0% — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — — —
Total Payout Ratio — — — 0.1% 0.1% 0.1% 0.4% — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -1.2% -79.5% -31.3% -53.0% -1.6% -4.6% -11.9% -15.7% -1.6% -37.3% -40.6% -67.8% -93.1% -93.05%
Total Shareholder Return -1.2% -79.5% -31.3% -53.0% -1.6% -4.6% -11.9% -15.7% -1.6% -37.3% -40.6% -67.8% -93.1% -93.05%
DuPont Factors
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.05 1.07 1.64 0.90 0.93 0.92 0.73 1.11 1.07 1.08 1.09 1.09 1.09 1.094
EBIT Margin — -16.39 -1.77 6.89 10.74 6.73 2.23 -10.15 -16.55 — — -203.04 -195.38 -195.383
Asset Turnover 0.00 0.05 0.02 0.05 0.08 0.13 0.07 0.05 0.06 0.00 0.00 0.01 0.01 0.007
Equity Multiplier -3.17 -0.10 -7.82 3.13 3.36 -0.46 24.82 3.93 3.50 3.17 7.48 -26.13 -12.31 -12.308
Per Share
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Current
EPS (Diluted TTM) $-11.00 $-13.44 $-2.01 $9.78 $14.67 $14.64 $3.43 $-13.63 $-21.28 $-19.44 $-14.55 $-13.41 $-12.97 $-12.97
Book Value/Share $-9.05 $-159.61 $-4.75 $10.70 $14.54 $11.93 $7.02 $2.34 $-2.86 $1.35 $-1.61 $-2.17 $0.31 $-2.65
Tangible Book/Share $-9.05 $-159.61 $-4.75 $10.70 $14.54 $11.93 $7.02 $2.34 $-2.86 $1.35 $-1.61 $-2.17 $0.31 $0.31
Revenue/Share $0.00 $0.77 $0.69 $1.58 $1.47 $2.35 $2.09 $1.21 $1.20 $0.00 $0.00 $0.06 $0.06 $0.00
FCF/Share $-8.35 $-11.98 $-12.32 $-15.43 $-15.26 $-15.31 $-14.78 $-15.69 $-16.18 $-16.36 $-12.47 $-11.10 $-10.96 $-13.56
OCF/Share $-8.35 $-11.98 $-12.31 $-15.40 $-15.21 $-15.21 $-14.65 $-15.57 $-16.09 $-16.30 $-12.45 $-11.07 $-10.93 $-13.51
Cash/Share $28.02 $12.06 $33.92 $30.76 $26.34 $24.95 $20.01 $15.82 $11.31 $13.08 $7.20 $6.88 $9.51 $8.40
EBITDA/Share $-10.47 $-12.53 $-1.20 $-8.87 $-2.60 $-3.58 $-14.71 $-12.25 $-19.77 $-17.99 $-13.47 $-12.39 $-11.93 $-11.93
Debt/Share $31.01 $21.86 $12.26 $12.40 $11.57 $12.25 $12.28 $12.20 $12.11 $10.67 $8.29 $7.69 $7.58 $7.58
Net Debt/Share $2.98 $9.80 $-21.66 $-18.37 $-14.77 $-12.70 $-7.74 $-3.63 $0.80 $-2.41 $1.09 $0.81 $-1.92 $-1.92
Academic Models
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Current
Altman Z-Score — — — — — — — — — — — — — -12.649
Altman Z-Prime snapshot only -28.756
Piotroski F-Score 2 2 1 2 5 5 4 1 3 1 1 1 4 4
Beneish M-Score — — — — — 0.40 — — — — — — — —
Ohlson O-Score snapshot only 2.930
ROIC (Greenblatt) snapshot only -28.88%
Net-Net WC snapshot only $-0.02
Credit
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Current
Credit Rating snapshot only CCC
Credit Score 14.67 20.00 20.00 81.67 82.83 53.39 36.70 16.06 15.26 16.41 17.79 15.24 16.67 16.668
Credit Grade snapshot only 17
Credit Trend snapshot only 1.411
Implied Spread (bps) snapshot only 1200.000
Industry Credit Rank snapshot only 8
Sector Credit Rank snapshot only 8

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms